ZOLINZA

ZOLINZA

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

Company

DUNS: 118446553

Effective Date

November 21, 2023

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Active Ingredients

Vorinostat(100 mg in 1 1)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

NDC Product Code

0006-0568

Application Number

NDA021991

Marketing Category

NDA (C73594)

Route of Administration

ORAL

Effective Date

July 13, 2022

Ingredients

Code: 58IFB293JIClass: ACTIBQuantity: 100 mg in 1 1

MAGNESIUM STEARATEInactive

Code: 70097M6I30Class: IACT

GELATIN, UNSPECIFIEDInactive

Code: 2G86QN327LClass: IACT

SODIUM LAURYL SULFATEInactive

Code: 368GB5141JClass: IACT

MICROCRYSTALLINE CELLULOSEInactive

Code: OP1R32D61UClass: IACT

CROSCARMELLOSE SODIUMInactive

Code: M28OL1HH48Class: IACT

TITANIUM DIOXIDEInactive

Code: 15FIX9V2JPClass: IACT